Patent Assignment
Reel/Frame 008530/0010
A Corrective Assignment to Correct Assignee Name and Address on Reel 8339, Frame 006.
Recorded: 1997-06-13
Pages: 4
Assignors
DUFOUR, JEAN-MARC
Executed: 1994-10-05
HOGAN, KEITH T.
Executed: 1994-10-05
FLANAGAN, RICHARD J.
Executed: 1994-10-05
Assignee
MERCK FROSST CANADA, INC.
16711 TRANS-CANADA HWY., KIRKLAND, QUEBEC, H9H 3, CANADA
Covered Property
(1)
Novel N3S2 Chelating Ligands Optionally Radiolabelled with Tc or Re Useful for Diagnostic or Therapeutic Applications
Patent:
5,632,969 →
Application:
08/322,881 →
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 5, 1997
From: FLANAGAN, RICHARD J.; DUFOUR, JEAN-MARC; HOGAN, KEITH T.
To: MERCK & CO., INC.
Reel/Frame 008339/0006 →
Change of Name
Jan 13, 1999
From: MERCK FROSST CANADA INCORPORATED
To: MERCK FROSST CANADA & CO.
Reel/Frame 009678/0146 →
Assignment of Assignor's Interest
Nov 10, 2005
From: MERCK FROSST CANADA & CO.
To: DRAXIMAGE, INC.
Reel/Frame 016996/0845 →
Amalgamation
Jul 11, 2008
From: DRAXIMAGE, INC.
To: DRAXIS SPECIALTY PHARMACEUTICALS INC.
Reel/Frame 021217/0625 →
Change of Name
Nov 11, 2010
From: DRAXIS SPECIALTY PHARMACEUTICALS INC.
To: JUBILANT DRAXIMAGE INC.
Reel/Frame 025348/0365 →